Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. The firm operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.
How did SHTDY's recent EPS compare to expectations?
The most recent EPS for Sinopharm Group Co. Ltd. is $, expectations of $.
How did Sinopharm Group Co. Ltd. SHTDY's revenue perform in the last quarter?
Sinopharm Group Co. Ltd. revenue for the last quarter is $
What is the revenue estimate for Sinopharm Group Co. Ltd.?
According to 3 of Wall street analyst, the revenue estimate of Sinopharm Group Co. Ltd. range from $299.23B to $279.28B
What's the earning quality score for Sinopharm Group Co. Ltd.?
Sinopharm Group Co. Ltd. has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Sinopharm Group Co. Ltd. report earnings?
Sinopharm Group Co. Ltd. next earnings report is expected in 2026-07-26
What are Sinopharm Group Co. Ltd.'s expected earnings?
Sinopharm Group Co. Ltd. expected earnings is $, according to wall-street analysts.
Did Sinopharm Group Co. Ltd. beat earnings expectations?
Sinopharm Group Co. Ltd. recent earnings of $ expectations.